Biopsy Devices Market Opportunity Analysis, 2018-2026

A biopsy is a sample of tissue taken from the body for in-depth analysis of the sample to reach an effective diagnosis of a condition, wherein conventional diagnostic methods such as x-rays and body scans do not provide any conclusive evidence. Biopsies are usually carried out to detect cancer, though their application is not restricted to it. This procedure is mostly performed by interventional radiologists, cardiologist and surgeons. Biopsy might be recommended in one of the following condition, among others:

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/220

-A mammogram shows a lump or mass, indicating the possibility of breast cancer
-A mole on the skin has changed shape recently and melanoma is possible
-A person suffers from chronic hepatitis and possibility of cirrhosis needs to be ruled out

Types of biopsies:

There are different kind of biopsies performed for different conditions and usually sharp tools are required to remove small amount of tissues. Listed below are some of the common types of biopsies:

-Needle biopsy
-CT-guided biopsy
-Bone biopsy
-Bone marrow biopsy
-Ultrasound-guided biopsy
-Liver biopsy
-Kidney biopsy
-Aspiration biopsy
-Skin biopsy
-Surgical biopsy

In biopsy, a sample of tissue is removed by a device and then sent to pathologist where thin slices are prepared and mounted on slides. The sample is then dyed and examined under a microscope to check for any abnormalities.

Global Biopsy Devices Market Outlook: Burgeoning growth in incidence rate of cancer fueling demand for preventive tests

High incidence of cancer is one of the main factor responsible for growth of the biopsy devices market. As per statistics released by the World Health Organization (WHO), around 14 million new cases of cancer were reported worldwide in 2012, with incidence rate expected to surge by exponentially by 70% over the following two decades. Furthermore, growing geriatric population characterized by a weak immune system, across the globe and increasing consumer health awareness leading to increasing preventive screening are other factors inadvertently fueling growth of the biopsy device market. Apart from this, stringent regulations posed on the companies in terms of labelling, designing and performance issues, as well as high cost of the devices are the major restrain factors which are hampering market growth. One of the main example of this is regular inspection by the regulatory authorities, in which evaluation of the equipment, records inspection and licensure are checked.

Global biopsy device market is projected to witness steady growth in the foreseeable future, with North America, followed by Europe being the largest revenue contributors collectively accounting for around 70% of the overall market. However, rampant increase in government spending on strengthening the healthcare infrastructure in emerging economies such as India and China, in turn is expected to position Asia Pacific as the fastest growing market for biopsy devices through 2024.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/220

Key Players in the Global Biopsy Devices Market:

Boston Scientific Carefusion
Cook Medical
C R Bard
Devicor Medical Products
Hologic
Intact Medical Corporation
Precision Biopsy, LLC
Scion Medical Technologies LLC
Integra LifeSciences Corporation
Creganna
Focal Therapeutics, Inc
Argon Medical Devices, Inc.
Becton, Dickinson and Company

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.